188 related articles for article (PubMed ID: 29112493)
1. [Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis].
Fernández-Ferreiro A; Luaces-Rodríguez A; Díaz-Tomé V; Gil-Martínez M; Rodríguez Ares MT; Touriño Peralba R; Blanco-Méndez J; González-Barcia M; Otero-Espinar FJ; Lamas MJ
Farm Hosp; 2017 Nov; 41(6):678-687. PubMed ID: 29112493
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis.
Marcano DC; Shin CS; Lee B; Isenhart LC; Liu X; Li F; Jester JV; Pflugfelder SC; Simpson J; Acharya G
Mol Pharm; 2016 Oct; 13(10):3468-3477. PubMed ID: 27571217
[TBL] [Abstract][Full Text] [Related]
3. Successful use of topical cysteamine formulated from the oral preparation in a child with keratopathy secondary to cystinosis.
Khan AO; Latimer B
Am J Ophthalmol; 2004 Oct; 138(4):674-5. PubMed ID: 15488810
[TBL] [Abstract][Full Text] [Related]
4. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.
Labbé A; Baudouin C; Deschênes G; Loirat C; Charbit M; Guest G; Niaudet P
Mol Genet Metab; 2014 Mar; 111(3):314-320. PubMed ID: 24440466
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical cysteamine in nephropathic cystinosis.
Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.
Simpson JL; Nien CJ; Flynn KJ; Jester JV
Mol Vis; 2011; 17():2649-54. PubMed ID: 22065917
[TBL] [Abstract][Full Text] [Related]
7. [Cysteamine eyedrops for treatment of corneal cysteine deposits in infantile cystinosis].
Gräf M; Grote A; Wagner F
Klin Monbl Augenheilkd; 1992 Jul; 201(1):48-50. PubMed ID: 1513127
[TBL] [Abstract][Full Text] [Related]
8. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.
Kaiser-Kupfer MI; Fujikawa L; Kuwabara T; Jain S; Gahl WA
N Engl J Med; 1987 Mar; 316(13):775-9. PubMed ID: 3821824
[TBL] [Abstract][Full Text] [Related]
9. NIH conference. Cystinosis: progress in a prototypic disease.
Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
[TBL] [Abstract][Full Text] [Related]
10. Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%.
Jones NP; Postlethwaite RJ; Noble JL
Br J Ophthalmol; 1991 May; 75(5):311-2. PubMed ID: 2036352
[TBL] [Abstract][Full Text] [Related]
11. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
[TBL] [Abstract][Full Text] [Related]
12. Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis.
McKenzie B; Kay G; Matthews KH; Knott R; Cairns D
Int J Pharm; 2016 Dec; 515(1-2):575-582. PubMed ID: 27771488
[TBL] [Abstract][Full Text] [Related]
13. A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis.
Bradbury JA; Danjoux JP; Voller J; Spencer M; Brocklebank T
Eye (Lond); 1991; 5 ( Pt 6)():755-60. PubMed ID: 1800180
[TBL] [Abstract][Full Text] [Related]
14. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.
Liang H; Labbé A; Le Mouhaër J; Plisson C; Baudouin C
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2275-2283. PubMed ID: 28426870
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
[TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
17. Nephropathic cystinosis in children: An overlooked disease.
Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.
Tavares R; Coelho D; Macário MC; Torres A; Quadrado MJ; Murta J
Cornea; 2009 Sep; 28(8):938-40. PubMed ID: 19654516
[TBL] [Abstract][Full Text] [Related]
19. [Ocular treatment of cystinosis with eye drop containing cysteamine].
Csorba A; Maka E; Szabó A; Kelen K; Reusz G; Nagy ZZ
Orv Hetil; 2022 May; 163(21):846-852. PubMed ID: 35598215
[TBL] [Abstract][Full Text] [Related]
20.
Ozdemir HB; Özmen MC; Aktas Z; Hasanreisoglu M
Indian J Ophthalmol; 2019 Jan; 67(1):153-155. PubMed ID: 30574930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
